MedPath

Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children

Phase 1
Completed
Conditions
HIV
Interventions
Behavioral: Teaching, Raising, and Communicating with Kids (TRACK)
Other: Treatment as usual
Registration Number
NCT00429546
Lead Sponsor
University of California, Los Angeles
Brief Summary

This study will develop and evaluate the effectiveness of an intervention designed to assist HIV-infected mothers of young children in determining whether and how to appropriately disclose their HIV serostatus to their children.

Detailed Description

HIV is a serious, life threatening illness that requires a lifetime of treatment and disease management. Studies have shown that it can be very difficult for infected mothers to decide whether and/or when to disclose their HIV serostatus to their uninfected children. HIV-infected parents struggle with the fear that their children will be forced to grow up too quickly, become worried or depressed, or be angry with their parents once they learn that their parents have HIV. Family-based intervention programs have been successful in helping facilitate the disclosure process. This study will develop and evaluate the effectiveness of an intervention designed to assist HIV-infected mothers of young children in determining whether and how to appropriately disclose their HIV serostatus to their children.

Participants in this study will be randomly assigned to either the intervention or a standard of care condition. The intervention will consist of three 75-minute sessions that will focus on exploring mothers' concerns, determining children's readiness to receive the news, planning for disclosure, and practicing disclosure. Participants will also receive one follow-up phone call from the therapist about 3 weeks after the last session. Sessions will be scheduled at times that are convenient for the participants and therapists. Follow-up visits will include both mothers and their children, and will be held at Months 3, 6, and 9 following the end of the intervention. Assessments will include readiness to disclose HIV serostatus, mental health indicators, and family functioning.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Confirmation of mother's HIV/AIDS status
  • Healthy child (i.e., HIV uninfected) who is between 6 and 12 years of age and is unaware of maternal serostatus
  • Mother is primary caregiver and child resides with her
  • English- or Spanish-speaking
Exclusion Criteria
  • Child does not meet screening criteria (e.g., diagnosed with depression or suicide attempt, IQ score less than 75)
  • Psychosis of parent or child (as advised by recruitment site clinicians)
  • Child refuses to give assent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
InterventionTeaching, Raising, and Communicating with Kids (TRACK)Participants will receive a cognitive-behavioral intervention designed to improve mother-child communication and parenting skills and prepare caregiver for disclosure of HIV serostatus to child
ControlTreatment as usualParticipants will receive treatment as usual
Primary Outcome Measures
NameTimeMethod
Readiness to disclose HIV serostatusMeasured at Months 3, 6, and 9
Disclosure of HIV serostatusMeasured at Months 3, 6, and 9
Secondary Outcome Measures
NameTimeMethod
Children's mental health indicatorsMeasured at Months 3, 6, and 9
Mothers' mental health indicatorsMeasured at Months 3, 6, and 9
Children's behavioral problemsMeasured at Months 3, 6, and 9
Parent-child relationship and family functioningMeasured at Months 3, 6, and 9

Trial Locations

Locations (1)

University of California, Los Angeles

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath